BRIEF RESEARCH REPORT
Published on 22 Jan 2025
PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database
doi 10.3389/fimmu.2025.1514033
- 745 views
- Frontiers in Immunology
- Alloimmunity and Transplantation
- Research Topics
- Impact of New Therapeutic Approaches for the Treatment of Post-transplant Tumors on the Outcome of the Transplanted Organ
Impact of New Therapeutic Approaches for the Treatment of Post-transplant Tumors on the Outcome of the Transplanted Organ
249
Total downloads
1,325
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.